Chanel Partners
LDS Pharma procures a wide range of pharmaceutical products from both multinational and local suppliers. Our teams collaborate closely with these suppliers throughout the entire process of creating commercial offers, which includes planning, design, distribution, and post-analysis. We are dedicated to implementing the suppliers’ intended strategies, achieving their goals and sales targets, and effectively positioning co-promoted products in comparison to competing brands
naprod Life Sciences
Naprod Life Sciences is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oncology and critical care products. With a commitment to innovation and excellence, Naprod Life Sciences aims to deliver cutting-edge therapies to improve patient outcomes worldwide. The company’s robust portfolio and state-of-the-art facilities ensure the highest standards of safety and efficacy in all their offerings.
Unijules Life Sciences
Unijules Life Sciences Ltd. based in India, specializes in the development, manufacturing, and marketing of pharmaceutical formulations, herbal products, and nutraceuticals. With a strong emphasis on research and innovation, the company aims to provide high-quality, affordable healthcare solutions. Unijules is committed to improving patient outcomes and enhancing the well-being of communities globally.
Nanjing Kingfriend Biochemical Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd (hereinafter referred to as NKF) is located in Nanjing High-Tech Zone, Nanjing, China. Established in 1986 as an API producer, we focus on research, production and sales of raw material medicines of heparin sodium. More than 30 years experience in the GMP manufacturing of Heparins and derivatives. With a commitment to quality and patient-centric care, NKF specializes in developing cutting-edge medications that address critical medical needs globally.
Actero Middle East
Actero is a pharmaceutical company specialized in high-quality oncology products in the Middle East. Its state-of-the-art facility is equipped with both injectable and solid dosage production lines under strict GMP standards. Actero is the result of the joint venture between Actoverco (the Iranian leading pharmaceutical company) and a renowned multinational company currently present in 120 countries.
IL-Yang Pharmaceutical
IL Yang Pharma Co. Ltd. established in 1946, South Korea, is a leading pharmaceutical company renowned for its innovative research and development in various therapeutic areas. The company specializes in the production of high-quality pharmaceuticals, including treatments for gastrointestinal diseases, oncology, and cardiovascular conditions. With a strong commitment to improving global health, Il Yang Pharma consistently invests in cutting-edge technologies and partnerships to enhance its product offerings and reach.
Jiangsu Hengrui Pharmaceuticals
Jiangsu Hengrui Medicine Co., Ltd. commonly known as Hengrui Pharmaceuticals, is a leading Chinese biopharmaceutical company renowned for its research-driven approach and diverse portfolio of therapeutic innovations. With a strong emphasis on quality and global standards, Hengrui Pharmaceuticals continues to make significant strides in oncology, anesthesia, and cardiovascular medicine, contributing to advancements in healthcare worldwide.
Incepta Vaccine
Incepta Pharmaceuticals Ltd. founded in 1999, is a leading pharmaceutical company in Bangladesh renowned for its commitment to producing high-quality and affordable vaccines. Vaccine Division operates a cutting-edge facility fully compliant with WHO GMP standards. This state-of-the-art manufacturing unit has the capability to produce 180 million single-dose vials and ampoules annually. A diverse team of scientists specializing in research and development, quality control, assurance, and production contributes to the division’s innovative efforts and operational excellence.